EUVIMEDEUVIMED entdecken
Open Access

National Analysis of the Requirements and Implementation of State Prescription Drug Price Transparency Laws

Hannah Rahim iD, Aaron S Kesselheim iD

The Milbank Quarterly · 2025

DOI: 10.1111/1468-0009.70023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Milbank Quarterly, 2025. Verfasst von Hannah Rahim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Law School. Hauptthemen laut MEDLINE: Prescription Drugs, Drug Costs, Drug Industry, Disclosure. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Policy Points A total of 21 states have passed drug price transparency laws with the goals of creating accountability around drug pricing and facilitating the development of policy solutions to address high prices. These laws vary in design but often require manufacturers to report the wholesale acquisition cost of drugs above a certain threshold for new drugs or of drugs that undergo a price increase above a certain margin, along with other data such as the manufacturer's costs. Initial findings suggest these laws may have contributed toward informing policymaking based on newly available public information but do not appear to have affected drug prices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prescription DrugsDrug CostsDrug IndustryDisclosureUnited StatesHumansState GovernmentHealth PolicyPolicy MakingPrice Transparency

Stichwörter der Autor:innen

pharmaceutical drugsprice reportingprice transparencystate legislationwholesale acquisition cost

Substanzen

Prescription Drugs

Autor:innen und Institutionen

  • Harvard Law School.
  • Harvard T.H. Chan School of Public Health.
  • Program on Regulation, Therapeutics, and Law (PORTAL), Harvard University.
  • Brigham and Women's Hospital, Harvard Medical School.

ORCID-Profile: Hannah Rahim, Aaron S Kesselheim

Zitieren

APA

Rahim, H., & Kesselheim, A. S. (2025). National Analysis of the Requirements and Implementation of State Prescription Drug Price Transparency Laws. The Milbank Quarterly. https://doi.org/10.1111/1468-0009.70023

Vancouver

Rahim H, Kesselheim AS. National Analysis of the Requirements and Implementation of State Prescription Drug Price Transparency Laws. The Milbank Quarterly. 2025. doi:10.1111/1468-0009.70023

BibTeX
@article{Rahim2025,
  author = {Rahim, Hannah and Kesselheim, Aaron S},
  title = {National Analysis of the Requirements and Implementation of State Prescription Drug Price Transparency Laws},
  journal = {The Milbank Quarterly},
  year = {2025},
  doi = {10.1111/1468-0009.70023}
}
Kostenlos starten →